Related Experiment Video
Updated: Jul 16, 2026
10:33
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Dendritic alpha,epsilon-poly(L-lysine)s as delivery agents for antisense oligonucleotides
Khee Dong Eom1, Sun Mi Park, Huu Dung Tran
1Nanormics Inc., Sungbuk-gu, Seoul, 136-130, South Korea.
Pharmaceutical Research
|March 22, 2007
Summary
Dendritic alpha,epsilon-poly(L-lysine)s (DPLs) show potential for delivering antisense oligonucleotides into cells. Higher generation DPLs are more effective, suggesting promise for gene delivery applications.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- Antisense oligonucleotides hold therapeutic potential but require efficient delivery systems.
- Dendritic polymers offer unique structural properties for biomolecular complexation.
Purpose of the Study:
- To assess dendritic alpha,epsilon-poly(L-lysine)s (DPLs) as carriers for antisense oligonucleotides.
- To investigate the impact of DPL generation on oligonucleotide delivery efficiency.
Main Methods:
- Synthesis and characterization of various generation DPLs.
- Evaluation of DPL-oligonucleotide complex formation using electrophoresis and microscopy.
- Assessment of cellular delivery and antisense effect in HeLa cells.
Main Results:
- DPLs formed complexes with antisense oligonucleotides with low cytotoxicity.
- Oligonucleotide-to-DPL charge ratio and DPL generation significantly influenced the antisense effect.
- Higher generation DPLs demonstrated enhanced cellular delivery of oligonucleotides.
Conclusions:
- High generation DPL-oligonucleotide complexes are moderately effective for antisense oligonucleotide delivery.
- DPLs show promise for in vivo gene and oligonucleotide delivery applications.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...